Replies to post #5939 on Todos Med Ltd (TOMDF)

[Oiloperator]

May fizzle but aint going away yet. Just hope next varient doesnt cause social kaos.been lucky new varient isnt more deadly. Next one who knows. Be prepared with food and daily needs. More impotant have extra strength tollovid foryour loved ones. Good luck to all

[theswordman]

So there may be several--usually label as severe to critical (S2C)
"hospitalized" is not a biomarker --I know that RLFT/NRXP is in that space w their IV version; they have a inhaled version/trial going also but believe it is mild/moderate type?? (they actually have 4-5 trials under way)
CYDY has a severe trial going and a critical trial/both IV--both in Brazil
Would guess there are 2 or 3 others that are trialling S2C --but might only be PHII??

[theswordman]

Follow up to "hospitalized" question and trials about other therapeutics

https://www.redhillbio.com/news/news-details/2022/RedHill-Biopharmas-Oral-Opaganib-Significantly-Improves-Viral-Clearance-in-Phase-23-Study-in-Severely-Ill-Hospitalized-COVID-19-Patients/default.aspx